Subsequent immunoglobulin and T‐cell receptor (TCR) rearrangement studies identified Ki‐1/CD30‐positive tumors as a special T‐cell derived lymphoma entity with frequent loss of T‐cell program [22]. The gene discussed is TNFRSF8; the disease is lymphoma.